Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Bellmunt, Joaquim, Hussain, Maha, Gschwend, Jürgen E, Albers, Peter, Oudard, Stephane, Castellano, Daniel, Daneshmand, Siamak, Nishiyama, Hiroyuki, Majchrowicz, Martin, Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, Drakaki, Alexandra, O'Donnell, Peter H, Rosenberg, Jonathan E, Geynisman, Daniel M, Petrylak, Daniel P, Hoffman-Censits, Jean, Bedke, Jens, Kalebasty, Arash Rezazadeh, Zakharia, Yousef, van der Heijden, Michiel S, Sternberg, Cora N, Davarpanah, Nicole N, Powles, Thomas
Published in The lancet oncology (01.04.2021)
Published in The lancet oncology (01.04.2021)
Get full text
Journal Article
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Plimack, Elizabeth R, Dr, Bellmunt, Joaquim, MD, Gupta, Shilpa, MD, Berger, Raanan, MD, Chow, Laura Q M, MD, Juco, Jonathan, MD, Lunceford, Jared, PhD, Saraf, Sanatan, PhD, Perini, Rodolfo F, MD, O'Donnell, Peter H, MD
Published in The lancet oncology (01.02.2017)
Published in The lancet oncology (01.02.2017)
Get full text
Journal Article
The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care
Truong, Tien M, Apfelbaum, Jeffrey, Shahul, Sajid, Anitescu, Magdalena, Danahey, Keith, Knoebel, Randall W, Liebovitz, David, Karrison, Theodore, van Wijk, Xander M R, Yeo, Kiang-Teck J, Meltzer, David, Ratain, Mark J, O'Donnell, Peter H
Published in Clinical pharmacology and therapeutics (01.12.2019)
Published in Clinical pharmacology and therapeutics (01.12.2019)
Get more information
Journal Article
Assessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal
Truong, Tien M., Lipschultz, Elizabeth, Danahey, Keith, Schierer, Emily, Ratain, Mark J., O'Donnell, Peter H.
Published in Clinical and translational science (01.01.2020)
Published in Clinical and translational science (01.01.2020)
Get full text
Journal Article
The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans
Friedman, Paula N., Shaazuddin, Mohammed, Gong, Li, Grossman, Robert L., Harralson, Arthur F., Klein, Teri E., Lee, Norman H., Miller, Doriane C., Nutescu, Edith A., O'Brien, Travis J., O'Donnell, Peter H., O'Leary, Kevin J., Tuck, Matthew, Meltzer, David O., Perera, Minoli A.
Published in Clinical and translational science (01.05.2019)
Published in Clinical and translational science (01.05.2019)
Get full text
Journal Article
Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system
Lipschultz, Elizabeth, Danahey, Keith, Truong, Tien M, Schierer, Emily, Volchenboum, Samuel L, Ratain, Mark J, O'Donnell, Peter H
Published in JAMIA open (01.07.2021)
Published in JAMIA open (01.07.2021)
Get full text
Journal Article
A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter, Niegisch, Günter, Galsky, Matthew D., Wong, Yu‐Ning, Ko, Yoo‐Joung, Stadler, Walter M., O'Donnell, Peter H., Sridhar, Srikala S., Vogelzang, Nicholas J., Necchi, Andrea, Di Lorenzo, Giuseppe, Sternberg, Cora N., Mehta, Amitkumar, Sonpavde, Guru
Published in BJU international (01.05.2014)
Published in BJU international (01.05.2014)
Get full text
Journal Article
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Balar, Arjun V, Castellano, Daniel, O'Donnell, Peter H, Grivas, Petros, Vuky, Jacqueline, Powles, Thomas, Plimack, Elizabeth R, Hahn, Noah M, de Wit, Ronald, Pang, Lei, Savage, Mary J, Perini, Rodolfo F, Keefe, Stephen M, Bajorin, Dean, Bellmunt, Joaquim
Published in The lancet oncology (01.11.2017)
Published in The lancet oncology (01.11.2017)
Get full text
Journal Article
Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant
Pai, Rish K., van Besien, Koen, Hart, John, Artz, Andrew S., O'Donnell, Peter H.
Published in Leukemia & lymphoma (01.08.2012)
Published in Leukemia & lymphoma (01.08.2012)
Get full text
Journal Article
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Rosenberg, Jonathan E, O'Donnell, Peter H, Balar, Arjun V, McGregor, Bradley A, Heath, Elisabeth I, Yu, Evan Y, Galsky, Matthew D, Hahn, Noah M, Gartner, Elaina M, Pinelli, Juan M, Liang, Shang-Ying, Melhem-Bertrandt, Amal, Petrylak, Daniel P
Published in Journal of clinical oncology (10.10.2019)
Published in Journal of clinical oncology (10.10.2019)
Get full text
Journal Article
Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science
Dolan, M Eileen, Maitland, Michael L, O Donnell, Peter H, Nakamura, Yusuke, Cox, Nancy J, Ratain, Mark J
Published in Pharmacogenomics (01.09.2013)
Published in Pharmacogenomics (01.09.2013)
Get full text
Journal Article
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
Vuky, Jacqueline, Balar, Arjun V, Castellano, Daniel, O'Donnell, Peter H, Grivas, Petros, Bellmunt, Joaquim, Powles, Thomas, Bajorin, Dean, Hahn, Noah M, Savage, Mary J, Fang, Xiao, Godwin, James Luke, Frenkl, Tara L, Homet Moreno, Blanca, de Wit, Ronald, Plimack, Elizabeth R
Published in Journal of clinical oncology (10.08.2020)
Published in Journal of clinical oncology (10.08.2020)
Get full text
Journal Article
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Yu, Evan Y, Petrylak, Daniel P, O'Donnell, Peter H, Lee, Jae-Lyun, van der Heijden, Michiel S, Loriot, Yohann, Stein, Mark N, Necchi, Andrea, Kojima, Takahiro, Harrison, Michael R, Hoon Park, Se, Quinn, David I, Heath, Elisabeth I, Rosenberg, Jonathan E, Steinberg, Joyce, Liang, Shang-Ying, Trowbridge, Janet, Campbell, Mary, McGregor, Bradley, Balar, Arjun V
Published in The lancet oncology (01.06.2021)
Published in The lancet oncology (01.06.2021)
Get full text
Journal Article
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Massard, Christophe, Gordon, Michael S, Sharma, Sunil, Rafii, Saeed, Wainberg, Zev A, Luke, Jason, Curiel, Tyler J, Colon-Otero, Gerardo, Hamid, Omid, Sanborn, Rachel E, O'Donnell, Peter H, Drakaki, Alexandra, Tan, Winston, Kurland, John F, Rebelatto, Marlon C, Jin, Xiaoping, Blake-Haskins, John A, Gupta, Ashok, Segal, Neil H
Published in Journal of clinical oncology (10.09.2016)
Published in Journal of clinical oncology (10.09.2016)
Get full text
Journal Article
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Rosenberg, Jonathan E, Dr, Hoffman-Censits, Jean, MD, Powles, Tom, Prof, van der Heijden, Michiel S, Prof, Balar, Arjun V, MD, Necchi, Andrea, MD, Dawson, Nancy, Prof, O'Donnell, Peter H, MD, Balmanoukian, Ani, MD, Loriot, Yohann, MD, Srinivas, Sandy, MD, Retz, Margitta M, Prof, Grivas, Petros, MD, Joseph, Richard W, MD, Galsky, Matthew D, MD, Fleming, Mark T, MD, Petrylak, Daniel P, Prof, Perez-Gracia, Jose Luis, MD, Burris, Howard A, MD, Castellano, Daniel, MD, Canil, Christina, MD, Bellmunt, Joaquim, MD, Bajorin, Dean, Prof, Nickles, Dorothee, PhD, Bourgon, Richard, PhD, Frampton, Garrett M, PhD, Cui, Na, PhD, Mariathasan, Sanjeev, PhD, Abidoye, Oyewale, MD, Fine, Gregg D, MD, Dreicer, Robert, Prof
Published in The Lancet (British edition) (07.05.2016)
Published in The Lancet (British edition) (07.05.2016)
Get full text
Journal Article
Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants
O'Donnell, Peter H, Gamazon, Eric, Zhang, Wei, Stark, Amy L, Kistner-Griffin, Emily O, Stephanie Huang, R, Eileen Dolan, M
Published in Pharmacogenetics and genomics (01.05.2010)
Published in Pharmacogenetics and genomics (01.05.2010)
Get more information
Journal Article
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study
Powles, Thomas, O'Donnell, Peter H, Massard, Christophe, Arkenau, Hendrik-Tobias, Friedlander, Terence W, Hoimes, Christopher J, Lee, Jae Lyun, Ong, Michael, Sridhar, Srikala S, Vogelzang, Nicholas J, Fishman, Mayer N, Zhang, Jingsong, Srinivas, Sandy, Parikh, Jigar, Antal, Joyce, Jin, Xiaoping, Gupta, Ashok K, Ben, Yong, Hahn, Noah M
Published in JAMA oncology (14.09.2017)
Published in JAMA oncology (14.09.2017)
Get more information
Journal Article